These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6809704

  • 1. Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group.
    Ydrach AA, Marcial VA, Parsons J, Concannon J, Asbell SO, George F.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):357-9. PubMed ID: 6809704
    [Abstract] [Full Text] [Related]

  • 2. Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignancies. Preliminary report of an ongoing RTOG phase I-II study.
    Meoz RT, Spanos WJ, Doss L, Johnson R, Wasserman TH.
    Am J Clin Oncol; 1983 Aug; 6(4):417-22. PubMed ID: 6191560
    [Abstract] [Full Text] [Related]

  • 3. Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial.
    Simpson JR, Perez CA, Phillips TL, Concannon JP, Carella RJ.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):303-8. PubMed ID: 7085386
    [Abstract] [Full Text] [Related]

  • 4. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
    Lee DJ, Pajak TF, Stetz J, Order SE, Weissberg JB, Fischer JJ.
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
    [Abstract] [Full Text] [Related]

  • 5. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M, Kramer S, Phillips T, Soberon M, Forgione H.
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [Abstract] [Full Text] [Related]

  • 6. Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
    Schwade JG, Kinsella TJ, Kelly B, Rowland J, Johnston M, Glatstein E.
    Cancer Invest; 1984 Oct; 2(2):91-5. PubMed ID: 6733563
    [Abstract] [Full Text] [Related]

  • 7. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.
    Leibel S, Bauer M, Wasserman T, Marcial V, Rotman M, Hornback N, Cooper J, Gillespie B, Pakuris E, Conner N.
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):541-9. PubMed ID: 3104249
    [Abstract] [Full Text] [Related]

  • 8. Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial.
    Simpson JR, Bauer M, Perez CA, Wasserman TH, Emami B, Doggett RL, Byhardt RW, Phillips TL, Mowry PA.
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1483-91. PubMed ID: 2542197
    [Abstract] [Full Text] [Related]

  • 9. A report on misonidazole in randomized trial in locally advanced head and neck cancer.
    Sealy R, Williams A, Cridland S, Stratford M, Minchinton A, Hallet C.
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(3-4):339-42. PubMed ID: 7050035
    [Abstract] [Full Text] [Related]

  • 10. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
    Grigsby PW, Winter K, Wasserman TH, Marcial V, Rotman M, Cooper J, Keys H, Asbell SO, Phillips TL.
    Int J Radiat Oncol Biol Phys; 1999 Jun 01; 44(3):513-7. PubMed ID: 10348279
    [Abstract] [Full Text] [Related]

  • 11. Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group.
    Simpson JR, Bauer M, Wasserman TH, Perez CA, Emami B, Wiegensberg I, Zinninger M, Durbin LM.
    Int J Radiat Oncol Biol Phys; 1987 Jun 01; 13(6):861-7. PubMed ID: 3034841
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
    Stehman FB, Bundy BN, Keys H, Currie JL, Mortel R, Creasman WT.
    Am J Obstet Gynecol; 1988 Jul 01; 159(1):87-94. PubMed ID: 3293456
    [Abstract] [Full Text] [Related]

  • 13. Pilot study of radiotherapy with misonidazole in head and neck cancer.
    Paterson IC, Dawes PJ, Henk JM, Moore JL.
    Clin Radiol; 1981 Mar 01; 32(2):225-9. PubMed ID: 7214840
    [Abstract] [Full Text] [Related]

  • 14. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck.
    Panis X, Nguyen TD, Froissart D, Demange L.
    Int J Radiat Oncol Biol Phys; 1984 Oct 01; 10(10):1845-9. PubMed ID: 6386760
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.